Revelation Biosciences, Inc. (REVB)
3.535
-0.26
(-6.73%)
USD |
NASDAQ |
Oct 26, 16:00
3.50
-0.04
(-0.99%)
After-Hours: 20:00
Revelation Biosciences EPS Diluted (Quarterly) : -6.075 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.075 |
| March 31, 2026 | -18.97 |
| December 31, 2025 | -11.53 |
| September 30, 2025 | -49.51 |
| June 30, 2025 | -196.26 |
| March 31, 2025 | -177.38 |
| December 31, 2024 | -418.35 |
| September 30, 2024 | -1124.15 |
| June 30, 2024 | -6895.59 |
| March 31, 2024 | -3306.79 |
| December 31, 2023 | -11192.03 |
| September 30, 2023 | -16828.76 |
| June 30, 2023 | -10046.13 |
| March 31, 2023 | 79191.71 |
| Date | Value |
|---|---|
| December 31, 2022 | -71293.82 |
| September 30, 2022 | -78462.72 |
| June 30, 2022 | -171658.4 |
| March 31, 2022 | -657464.0 |
| December 31, 2021 | -551863.9 |
| September 30, 2021 | -682865.6 |
| June 30, 2021 | -553924.2 |
| March 31, 2021 | -586071.4 |
| December 31, 2020 | -251588.7 |
| September 30, 2020 | -127.01 |
| June 30, 2020 | -42.34 |
| March 31, 2020 | -1114.85 |
| December 31, 2019 | -564.48 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | -3.098 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Agenus, Inc. | -0.0146 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.323M |
| Total Expenses (Quarterly) | 3.323M |
| Enterprise Value | -8.769M |
| Earnings Yield | -2.44K% |
| Normalized Earnings Yield | -2435.45 |